Annual Operating Expenses
$661.60 M
+$61.50 M+10.25%
December 1, 2023
Summary
- As of February 7, 2025, MYGN annual total operating expenses is $661.60 million, with the most recent change of +$61.50 million (+10.25%) on December 1, 2023.
- During the last 3 years, MYGN annual operating expenses has risen by +$365.40 million (+123.36%).
- MYGN annual operating expenses is now at all-time high.
Performance
MYGN Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$167.60 M
-$4.40 M-2.56%
September 1, 2024
Summary
- As of February 7, 2025, MYGN quarterly total operating expenses is $167.60 million, with the most recent change of -$4.40 million (-2.56%) on September 1, 2024.
- Over the past year, MYGN quarterly operating expenses has increased by +$2.10 million (+1.27%).
- MYGN quarterly operating expenses is now -15.95% below its all-time high of $199.40 million, reached on September 30, 2021.
Performance
MYGN Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
MYGN Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.3% | +1.3% |
| 3 y3 years | +123.4% | -1.4% |
| 5 y5 years | +3.0% | +8.6% |
MYGN Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +10.3% | -3.8% | +74.4% |
| 5 y | 5-year | at high | +123.4% | -15.9% | +74.4% |
| alltime | all time | at high | +3769.0% | -15.9% | +492.4% |
Myriad Genetics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $167.60 M(-2.6%) |
| Jun 2024 | - | $172.00 M(+3.9%) |
| Mar 2024 | - | $165.50 M(+0.1%) |
| Dec 2023 | $661.60 M(+10.2%) | $165.40 M(+3.3%) |
| Sep 2023 | - | $160.10 M(-1.1%) |
| Jun 2023 | - | $161.90 M(-7.1%) |
| Mar 2023 | - | $174.20 M(+2.5%) |
| Dec 2022 | $600.10 M(-3.2%) | $169.90 M(+12.5%) |
| Sep 2022 | - | $151.00 M(+2.4%) |
| Jun 2022 | - | $147.40 M(+11.8%) |
| Mar 2022 | - | $131.80 M(+37.1%) |
| Dec 2021 | $619.70 M(+109.2%) | $96.10 M(-51.8%) |
| Sep 2021 | - | $199.40 M(+28.9%) |
| Jun 2021 | - | $154.70 M(-8.2%) |
| Mar 2021 | - | $168.60 M(+19.0%) |
| Dec 2020 | $296.20 M(-49.3%) | - |
| Sep 2020 | - | $141.70 M(+16.1%) |
| Jun 2020 | $584.50 M(-9.0%) | $122.00 M(-20.1%) |
| Mar 2020 | - | $152.60 M(-1.2%) |
| Dec 2019 | - | $154.40 M(-1.5%) |
| Sep 2019 | - | $156.80 M(-8.7%) |
| Jun 2019 | $642.50 M(+27.0%) | $171.80 M(+6.0%) |
| Mar 2019 | - | $162.10 M(+2.9%) |
| Dec 2018 | - | $157.60 M(+4.4%) |
| Sep 2018 | - | $151.00 M(+15.8%) |
| Jun 2018 | $505.80 M(-1.7%) | $130.40 M(+3.2%) |
| Mar 2018 | - | $126.40 M(+1.8%) |
| Dec 2017 | - | $124.20 M(-0.6%) |
| Sep 2017 | - | $125.00 M(+19.7%) |
| Jun 2017 | $514.30 M(+19.7%) | $104.40 M(-25.3%) |
| Mar 2017 | - | $139.70 M(+0.6%) |
| Dec 2016 | - | $138.90 M(+5.8%) |
| Sep 2016 | - | $131.30 M(+18.4%) |
| Jun 2016 | $429.80 M(-2.7%) | $110.90 M(+3.0%) |
| Mar 2016 | - | $107.70 M(+0.2%) |
| Dec 2015 | - | $107.50 M(+3.7%) |
| Sep 2015 | - | $103.70 M(-10.1%) |
| Jun 2015 | $441.50 M(+11.9%) | $115.30 M(+6.8%) |
| Mar 2015 | - | $108.00 M(-2.0%) |
| Dec 2014 | - | $110.20 M(+2.0%) |
| Sep 2014 | - | $108.00 M(+3.3%) |
| Jun 2014 | $394.60 M(+29.2%) | $104.56 M(+3.5%) |
| Mar 2014 | - | $101.03 M(+6.4%) |
| Dec 2013 | - | $94.93 M(+0.9%) |
| Sep 2013 | - | $94.08 M(+9.3%) |
| Jun 2013 | $305.50 M(+21.7%) | $86.08 M(+10.0%) |
| Mar 2013 | - | $78.22 M(+6.2%) |
| Dec 2012 | - | $73.67 M(+9.1%) |
| Sep 2012 | - | $67.53 M(-1.7%) |
| Jun 2012 | $251.03 M(+27.0%) | $68.73 M(+3.4%) |
| Mar 2012 | - | $66.45 M(+8.5%) |
| Dec 2011 | - | $61.23 M(+12.1%) |
| Sep 2011 | - | $54.62 M(+2.8%) |
| Jun 2011 | $197.59 M(+7.8%) | $53.11 M(+7.5%) |
| Mar 2011 | - | $49.42 M(-0.8%) |
| Dec 2010 | - | $49.81 M(+10.1%) |
| Sep 2010 | - | $45.26 M(+0.5%) |
| Jun 2010 | $183.29 M | $45.05 M(-3.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $46.73 M(-0.9%) |
| Dec 2009 | - | $47.16 M(+6.3%) |
| Sep 2009 | - | $44.35 M(+9.8%) |
| Jun 2009 | $156.80 M(+21.6%) | $40.40 M(+0.9%) |
| Mar 2009 | - | $40.04 M(+1.2%) |
| Dec 2008 | - | $39.58 M(-21.7%) |
| Sep 2008 | - | $50.55 M(-218.4%) |
| Jun 2008 | $128.91 M(-25.9%) | -$42.71 M(-169.6%) |
| Mar 2008 | - | $61.32 M(+6.1%) |
| Dec 2007 | - | $57.79 M(+10.0%) |
| Sep 2007 | - | $52.51 M(+4.7%) |
| Jun 2007 | $174.04 M(+31.6%) | $50.14 M(+18.0%) |
| Mar 2007 | - | $42.48 M(+133.0%) |
| Dec 2006 | - | $18.24 M(-54.9%) |
| Sep 2006 | - | $40.44 M(+6.6%) |
| Jun 2006 | $132.22 M(+28.6%) | $37.94 M(+10.8%) |
| Mar 2006 | - | $34.26 M(+11.7%) |
| Dec 2005 | - | $30.66 M(+4.4%) |
| Sep 2005 | - | $29.36 M(+0.6%) |
| Jun 2005 | $102.83 M(+20.2%) | $29.18 M(+15.0%) |
| Mar 2005 | - | $25.37 M(+0.8%) |
| Dec 2004 | - | $25.18 M(+9.1%) |
| Sep 2004 | - | $23.09 M(+4.2%) |
| Jun 2004 | $85.53 M(+8.1%) | $22.16 M(+4.5%) |
| Mar 2004 | - | $21.21 M(+0.6%) |
| Dec 2003 | - | $21.08 M(-0.0%) |
| Sep 2003 | - | $21.08 M(+4.9%) |
| Jun 2003 | $79.11 M(+28.1%) | $20.10 M(+6.7%) |
| Mar 2003 | - | $18.84 M(-12.4%) |
| Dec 2002 | - | $21.51 M(+15.3%) |
| Sep 2002 | - | $18.66 M(+0.6%) |
| Jun 2002 | $61.78 M(+21.4%) | $18.55 M(+26.6%) |
| Mar 2002 | - | $14.65 M(-0.3%) |
| Dec 2001 | - | $14.69 M(+5.8%) |
| Sep 2001 | - | $13.88 M(+15.2%) |
| Jun 2001 | $50.90 M(+13.5%) | $12.05 M(-4.9%) |
| Mar 2001 | - | $12.68 M(-5.6%) |
| Dec 2000 | - | $13.43 M(+5.5%) |
| Sep 2000 | - | $12.73 M(+2.4%) |
| Jun 2000 | $44.86 M(+18.7%) | $12.44 M(-0.1%) |
| Mar 2000 | - | $12.45 M(+20.9%) |
| Dec 1999 | - | $10.30 M(+6.2%) |
| Sep 1999 | - | $9.70 M(0.0%) |
| Jun 1999 | $37.80 M(-0.8%) | $9.70 M(+2.1%) |
| Mar 1999 | - | $9.50 M(0.0%) |
| Dec 1998 | - | $9.50 M(+3.3%) |
| Sep 1998 | - | $9.20 M(-14.0%) |
| Jun 1998 | $38.10 M(+27.4%) | $10.70 M(+11.5%) |
| Mar 1998 | - | $9.60 M(+10.3%) |
| Dec 1997 | - | $8.70 M(-4.4%) |
| Sep 1997 | - | $9.10 M(+7.1%) |
| Jun 1997 | $29.90 M(+74.9%) | $8.50 M(+16.4%) |
| Mar 1997 | - | $7.30 M(-3.9%) |
| Dec 1996 | - | $7.60 M(+18.8%) |
| Sep 1996 | - | $6.40 M(+20.8%) |
| Jun 1996 | $17.10 M | $5.30 M(+6.0%) |
| Mar 1996 | - | $5.00 M(+38.9%) |
| Dec 1995 | - | $3.60 M |
FAQ
- What is Myriad Genetics annual total operating expenses?
- What is the all time high annual operating expenses for Myriad Genetics?
- What is Myriad Genetics annual operating expenses year-on-year change?
- What is Myriad Genetics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Myriad Genetics?
- What is Myriad Genetics quarterly operating expenses year-on-year change?
What is Myriad Genetics annual total operating expenses?
The current annual operating expenses of MYGN is $661.60 M
What is the all time high annual operating expenses for Myriad Genetics?
Myriad Genetics all-time high annual total operating expenses is $661.60 M
What is Myriad Genetics annual operating expenses year-on-year change?
Over the past year, MYGN annual total operating expenses has changed by +$61.50 M (+10.25%)
What is Myriad Genetics quarterly total operating expenses?
The current quarterly operating expenses of MYGN is $167.60 M
What is the all time high quarterly operating expenses for Myriad Genetics?
Myriad Genetics all-time high quarterly total operating expenses is $199.40 M
What is Myriad Genetics quarterly operating expenses year-on-year change?
Over the past year, MYGN quarterly total operating expenses has changed by +$2.10 M (+1.27%)